FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
RU2200161C2
(ru)
|
1996-12-31 |
2003-03-10 |
Др. Редди'З Рисерч Фаундейшн |
Новые производные азолидиндиона, способ их получения (варианты), фармацевтические композиции на их основе, способ предупреждения или лечения, способ снижения глюкозы и промежуточное соединение
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
BR9810592A
(pt)
|
1997-07-16 |
2000-09-12 |
Novo Nordisk As |
Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
PL343419A1
(en)
|
1998-03-12 |
2001-08-13 |
Microbial Chem Res Found |
Benzofurylpyrone derivatives
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
CA2353574C
(fr)
|
1998-12-07 |
2012-05-08 |
Zheng Xin Dong |
Analogues du glp-1
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
US6608185B1
(en)
|
1999-03-25 |
2003-08-19 |
Kitasato Institute |
Substances KF-1040T4A,KF-1040T4B, KF-1040T5A, and KF-1040T5B, and process for producing same
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
EP1173438A1
(fr)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Imidazoles substitues, leur preparation et utilisation
|
WO2000064884A1
(fr)
|
1999-04-26 |
2000-11-02 |
Novo Nordisk A/S |
Derives de piperidyle-imidazole, preparations dans lesquelles ils entrent et utilisations therapeutiques de ces dernieres
|
CA2371271A1
(fr)
|
1999-04-30 |
2000-11-09 |
Neurogen Corporation |
Derives 9h-pyrimido[4,5-b]indoles: ligands specifiques de crf1
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
DE60014083T2
(de)
|
1999-06-15 |
2006-03-02 |
Bristol-Myers Squibb Pharma Co., Wilmington |
Substituierte heterocyclylkondensierte gamma carboline
|
DK1194425T3
(da)
|
1999-06-23 |
2005-11-21 |
Aventis Pharma Gmbh |
Substituerede benzimidazoler
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
EP1076066A1
(fr)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides abaissant le taux de glucose sanguin
|
PT1204654E
(pt)
|
1999-07-29 |
2003-11-28 |
Lilly Co Eli |
Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina
|
FR2796945B1
(fr)
*
|
1999-07-30 |
2002-06-28 |
Sod Conseils Rech Applic |
Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
|
EE200200095A
(et)
|
1999-09-01 |
2003-04-15 |
Aventis Pharma Deutschland Gmbh |
Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
|
WO2001017516A2
(fr)
|
1999-09-10 |
2001-03-15 |
Novo Nordisk A/S |
Procede d'inhibition de la proteine tyrosine phosphatase 1b et/ou de la proteine tyrosine phosphatase de lymphocytes et/ou d'autres ptpases possedant un reste aps en position 48
|
JP2003509429A
(ja)
|
1999-09-10 |
2003-03-11 |
ノボ ノルディスク アクティーゼルスカブ |
タンパク質チロシンホスファターゼ(ptpアーゼ)のモジュレーター
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
IL151452A0
(en)
|
2000-03-23 |
2003-04-10 |
Solvay Pharm Bv |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
BR0109625A
(pt)
|
2000-03-31 |
2003-04-22 |
Pfizer Prod Inc |
cidos malonñmicos e seus derivados como ligandos do receptor da tireóide
|
AU2001252574B2
(en)
|
2000-04-28 |
2005-03-17 |
Asahi Kasei Pharma Corporation |
Novel bicyclic compounds
|
US6838465B2
(en)
|
2000-05-11 |
2005-01-04 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
BR0110638A
(pt)
|
2000-05-11 |
2003-03-25 |
Bristol Myers Squibb Co |
Análogos de tetraidroisoquinolina úteis como secretagogos de hormÈnio do crescimento
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU2001264977B2
(en)
|
2000-05-30 |
2005-04-14 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
JP4611608B2
(ja)
|
2000-06-16 |
2011-01-12 |
スミスクライン ビーチャム ピー エル シー |
オレキシン受容体アンタゴニストとして使用するためのピペリジン
|
AU783403B2
(en)
|
2000-07-05 |
2005-10-20 |
H. Lundbeck A/S |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
|
JP2004502423A
(ja)
|
2000-07-05 |
2004-01-29 |
シナプティック・ファーマスーティカル・コーポレーション |
ヒトメラニン濃縮ホルモン受容体(mch1)をコードするdna及びその使用
|
EP1330457B1
(fr)
|
2000-11-03 |
2004-10-20 |
Wyeth |
Cyclopenta [b][1,4]diazepino 6,7,1-hi]indoles comme antagonistes de 5ht2c
|
US6825220B2
(en)
|
2000-11-10 |
2004-11-30 |
Eli Lilly And Company |
3-Substituted oxindole β 3 agonists
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
AU2002216097B2
(en)
|
2000-12-21 |
2006-09-07 |
Sanofi-Aventis Deutschland Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
EP1345925B1
(fr)
|
2000-12-21 |
2006-05-17 |
Vertex Pharmaceuticals Incorporated |
Composes de pyrazole presentant une grande utilite comme inhibiteurs de proteine kinase
|
NZ526594A
(en)
|
2000-12-21 |
2004-08-27 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
SI1373216T1
(en)
|
2001-03-22 |
2005-06-30 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
CA2446351A1
(fr)
|
2001-05-04 |
2002-11-14 |
Tularik Inc. |
Composes heterocycliques fondus
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
AU2002345320A1
(en)
|
2001-06-28 |
2003-03-03 |
Algat Sherutey Gimur Teufati |
Treatment for improved magnesium surface corrosion-resistance
|
KR20040027870A
(ko)
|
2001-07-05 |
2004-04-01 |
시냅틱 파마세틱칼 코포레이션 |
Mch 선택적인 안타고니스트로서의 치환 아닐린 피페리딘
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
AU2002331064B2
(en)
|
2001-08-10 |
2007-08-23 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10142734A1
(de)
|
2001-08-31 |
2003-03-27 |
Aventis Pharma Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CN1555262A
(zh)
|
2001-09-21 |
2004-12-15 |
������ҩ������˾ |
具有cb1-拮抗活性的新的4,5-二氢-1h-吡唑衍生物
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
PE20030547A1
(es)
|
2001-09-24 |
2003-08-18 |
Bayer Corp |
Derivados de imidazol para el tratamiento de la obesidad
|
EP1432679A1
(fr)
|
2001-09-24 |
2004-06-30 |
Bayer Pharmaceuticals Corporation |
Preparation et utilisation de derives du pyrrole traitant l'obesite
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
CN1649855A
(zh)
|
2001-11-22 |
2005-08-03 |
比奥维特罗姆股份公司 |
11-β-羟基类固醇脱氢酶1型抑制剂
|
AU2002353716A1
(en)
|
2001-11-22 |
2003-06-10 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
DE60236541D1
(de)
|
2001-11-22 |
2010-07-08 |
Biovitrum Ab |
Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
|
GB0202015D0
(en)
|
2002-01-29 |
2002-03-13 |
Hoffmann La Roche |
Piperazine Derivatives
|
DE60317631T2
(de)
|
2002-02-01 |
2008-09-25 |
Merck & Co., Inc. |
11-beta-hydroxysteroid-dehydrogenase-1-hemmer zur behandlung von diabetes, adipositas und dyslipidämie
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
KR20040095239A
(ko)
|
2002-02-27 |
2004-11-12 |
화이자 프로덕츠 인코포레이티드 |
Acc 억제제
|
CA2477967C
(fr)
|
2002-03-05 |
2010-08-10 |
Eli Lilly And Company |
Derives de la purine en tant qu'inhibiteurs de la kinase
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
CA2480856A1
(fr)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Arylamides substituee
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
JP4459629B2
(ja)
|
2002-04-12 |
2010-04-28 |
メルク エンド カムパニー インコーポレーテッド |
二環式アミド
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
EP1539730A4
(fr)
|
2002-07-09 |
2007-03-28 |
Fasgen Inc |
Nouveaux composes, compositions pharmaceutiques les contenant et methodes d'utilisation desdits composes
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
WO2004007455A1
(fr)
|
2002-07-12 |
2004-01-22 |
Aventis Pharma Deutschland Gmbh |
Benzoyl urees a substitution heterocyclique, procedes pour leur production et leur utilisation comme medicaments
|
IL150914A
(en)
|
2002-07-25 |
2014-04-30 |
Zamir Tribelsky |
A method for hydro-optronio photochemical treatment of liquids
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2004011410A1
(fr)
|
2002-07-27 |
2004-02-05 |
Astrazeneca Ab |
Composes chimiques
|
CA2493313C
(fr)
|
2002-07-29 |
2010-03-09 |
F. Hoffmann-La Roche Ag |
Nouveaux benzodioxoles
|
KR20050069977A
(ko)
|
2002-08-07 |
2005-07-05 |
미쯔비시 웰 파마 가부시키가이샤 |
디히드로피라졸로피리딘 화합물
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
PL374946A1
(en)
|
2002-09-05 |
2005-11-14 |
Aventis Pharma S.A. |
Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
CA2499497A1
(fr)
|
2002-09-27 |
2004-04-08 |
Merck & Co., Inc. |
Pyrimidines substituees
|
US20050256159A1
(en)
|
2002-10-11 |
2005-11-17 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
|
MXPA05004115A
(es)
|
2002-10-18 |
2005-06-22 |
Pfizer Prod Inc |
Ligandos del receptor cannabionoide y usos de los mismos.
|
KR20050067418A
(ko)
|
2002-10-18 |
2005-07-01 |
머크 앤드 캄파니 인코포레이티드 |
당뇨병을 치료 또는 예방하기 위한 베타-아미노헤테로사이클릭 디펩티딜 펩티다제 억제제
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
JP2006514614A
(ja)
|
2002-10-24 |
2006-05-11 |
ステリックス リミテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型および2型のインヒビター
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
AU2003291342A1
(en)
|
2002-11-05 |
2004-06-07 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
US20060058315A1
(en)
|
2002-11-07 |
2006-03-16 |
Astrazeneca Ab |
2-Oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
JP4719469B2
(ja)
|
2002-12-19 |
2011-07-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
置換アミド類
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
WO2004056744A1
(fr)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides utilises comme inhibiteurs de la hydroxysteroide deshydrogenase
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
CA2509086C
(fr)
|
2003-01-06 |
2012-08-21 |
Eli Lilly And Company |
Arylcyclopropylacetamides substitues servant d'activateurs de glucokinase
|
GEP20084540B
(en)
|
2003-01-14 |
2008-11-25 |
Arena Pharm Inc |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
US7262196B2
(en)
|
2003-02-11 |
2007-08-28 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
AU2004212043A1
(en)
|
2003-02-13 |
2004-08-26 |
Sanofi-Aventis Deutschland Gmbh |
Nitrogen-substituted hexahydropyrazino(1,2-a)pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
|
PL377227A1
(pl)
|
2003-02-13 |
2006-01-23 |
Sanofi-Aventis Deutschland Gmbh |
Postawione pochodne heksahydropirazyno [1,2-a] pirymidyno-4,7-dionu, sposób ich wytwarzania i ich zastosowanie jako środków leczniczych
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
PL378555A1
(pl)
|
2003-02-19 |
2006-05-02 |
F. Hoffmann-La Roche Ag |
Sulfonoamido-podstawione pochodne ksantyny do stosowania jako inhibitory PEPCK
|
AR043434A1
(es)
|
2003-03-03 |
2005-07-27 |
Merck & Co Inc |
Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4. composiciones farmaceuticas y usos
|
EP1460069A1
(fr)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Dérivés substitués du cyclohexane et de la pipéridine comme modulateurs du récepteur de la melanocortine-4
|
EP1460075A1
(fr)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Derivées substituées de 8-perfluoro-6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-one
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
CN1764458A
(zh)
|
2003-03-26 |
2006-04-26 |
麦克公司 |
作为黑皮质素-4受体激动剂的双环哌啶衍生物
|
BRPI0408681A
(pt)
|
2003-03-26 |
2006-03-28 |
Actelion Pharmaceuticals Ltd |
compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
EP1615698B1
(fr)
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
Nouvelles amides substitues et leur utilisation pharmaceutique
|
CA2521832A1
(fr)
|
2003-04-11 |
2004-10-28 |
Smithkline Beecham Corporation |
Antagonistes heterocycliques de mchr1
|
JP2006522747A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
縮合1,2,4−トリアゾールの薬学的使用
|
WO2004089367A1
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Utilisation pharmaceutique de 1,2,4-triazoles substituees
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
CN100472485C
(zh)
|
2003-04-25 |
2009-03-25 |
松下电器产业株式会社 |
服务器及服务器的处理方法
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
JP2006525297A
(ja)
|
2003-05-01 |
2006-11-09 |
ヴァーナリス リサーチ リミテッド |
治療におけるアゼチジンカルボキサミド誘導体の使用
|
CA2524251A1
(fr)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Derives d'azetidinecarboxamide et leur utilisation dans le traitement de troubles medies par les recepteur cb1
|
JP2006525299A
(ja)
|
2003-05-01 |
2006-11-09 |
ヴァーナリス リサーチ リミテッド |
アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用
|
WO2004100875A2
(fr)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions contenant lesdits composes et methodes d'utilisation
|
MXPA05011922A
(es)
|
2003-05-07 |
2006-02-17 |
Pfizer Prod Inc |
Ligandos del receptor de cannabinoides y sus usos.
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
EP1631558A1
(fr)
|
2003-05-21 |
2006-03-08 |
Biovitrum Ab |
Inhibiteurs de 11-beta-hydroxy steroide deshydrogenase de type i
|
EP1651229A1
(fr)
|
2003-05-23 |
2006-05-03 |
Chiron Corporation |
Composes de quinazoline substitues par guanidino constituant des agonistes de mc4-r
|
US8026264B2
(en)
|
2003-05-29 |
2011-09-27 |
Merck Sharp And Dohme Corp. |
Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(fr)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Molecules et analogues de la famille agelastatine d'alkaloides antitumuraux et inhibiteurs de gsk-3?
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
JP3939744B2
(ja)
|
2003-06-11 |
2007-07-04 |
メルク エンド カムパニー インコーポレーテッド |
置換3−アルキルおよび3−アルケニルアゼチジン誘導体
|
JP2007500748A
(ja)
|
2003-06-13 |
2007-01-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤としての置換インダゾリル(インドリル)マレイミド誘導体
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
AU2004247615B2
(en)
|
2003-06-18 |
2008-02-21 |
Astrazeneca Ab |
2-substituted 5,6-diaryl-pyrazine derivatives as CB1 modulators
|
JP2006527773A
(ja)
|
2003-06-19 |
2006-12-07 |
イーライ リリー アンド カンパニー |
メラノコルチン受容体4(mc4)作用薬とその用途
|
ATE390922T1
(de)
|
2003-06-20 |
2008-04-15 |
Hoffmann La Roche |
2-aminobenzothiazole als cb1 rezeptor inverse agonisten
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
WO2004113310A1
(fr)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Utilisation d'un inhibiteur de compose de type 1 11-b-hydroxysteroide deshydrogenase type 1 destine a faciliter la cicatrisation d'une plaie
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
US7029524B2
(en)
|
2003-06-27 |
2006-04-18 |
Day-Glo Color Corp. |
Water-based spray marking composition
|
CN101431016B
(zh)
|
2003-06-27 |
2013-02-13 |
日本电气株式会社 |
多晶半导体薄膜的制造方法
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
EP1644399A2
(fr)
|
2003-07-09 |
2006-04-12 |
Forbes Medi-Tech Inc. |
Nouveaux composes et compositions comprenant des sterols et/ou des stanols et des inhibiteurs de biosynthese du cholesterol et utilisation associees pour le traitement et la prevention de maladies et d'etats divers
|
DE10331074A1
(de)
|
2003-07-09 |
2005-02-03 |
Conti Temic Microelectronic Gmbh |
Sensoranordnung zur Abstands- und/oder Geschwindigkeitsmessung
|
WO2005007628A1
(fr)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Derives de tetrahydroquinoleine constituant des modulateurs des recepteurs des cannabinoides
|
WO2005005477A2
(fr)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Compositions d'insuline stabilisee
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
WO2005009950A2
(fr)
|
2003-07-22 |
2005-02-03 |
Merck & Co., Inc. |
Derives de piperidine utilises en tant qu'agonistes du recepteur de la melanocortine 4
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
JP2007501789A
(ja)
|
2003-08-07 |
2007-02-01 |
メルク エンド カムパニー インコーポレーテッド |
11−β−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのピラゾールカルボキサミド
|
WO2005013907A2
(fr)
|
2003-08-07 |
2005-02-17 |
Japan Tobacco Inc. |
Derives de pyrrolo[1,2-b]pyridazine
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
JP2007502283A
(ja)
|
2003-08-13 |
2007-02-08 |
アムジェン インコーポレイテッド |
メラニン凝集ホルモン受容体アンタゴニスト
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
WO2005021495A2
(fr)
|
2003-08-25 |
2005-03-10 |
Microbia Inc. |
Derives sels quaternaires de 1,4-diphenylazetidin-2-ones
|
WO2005021497A2
(fr)
|
2003-08-28 |
2005-03-10 |
Microbia, Inc. |
Trimeres et dimeres fixes de 1,4-diphenylazetidin-2-ones
|
US20070105914A1
(en)
|
2003-09-18 |
2007-05-10 |
Armstrong Helen M |
Substituted sulfonamides
|
EP1670515A2
(fr)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Derives de peptides therapeutiques liant l'albumine
|
AR045651A1
(es)
|
2003-09-19 |
2005-11-02 |
Solvay Pharm Bv |
Derivados de tiazol como moduladores del receptor de cannabinoide
|
US20050070712A1
(en)
|
2003-09-26 |
2005-03-31 |
Christi Kosogof |
Pyrimidine derivatives as ghrelin receptor modulators
|
CN101497654A
(zh)
|
2003-09-30 |
2009-08-05 |
诺沃挪第克公司 |
黑皮素受体激动剂
|
EP1522541A1
(fr)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Nouveaux composés hypocholesterolémiques
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
WO2005040109A1
(fr)
|
2003-10-22 |
2005-05-06 |
Neurocrine Biosciences, Inc. |
Ligands du recepteur de la melanocortine et compositions et methodes associees
|
GB0325192D0
(en)
|
2003-10-29 |
2003-12-03 |
Astrazeneca Ab |
Method of use
|
AU2004286838A1
(en)
|
2003-10-30 |
2005-05-19 |
Merck & Co., Inc. |
2-azetidinones as anti-hypercholesterolemic agents
|
WO2005042692A2
(fr)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
Methode permettant d'inhiber l'expression de genes qui induisent l'influx de cholesterol cellulaire dans les cellules animales et d'inhiber la production de proteines issues de l'expression de ces genes
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
JP2007509997A
(ja)
|
2003-11-07 |
2007-04-19 |
エフ.ホフマン−ラ ロシュ アーゲー |
ベンゾ[b][1,4]ジオキセピン誘導体
|
PL380414A1
(pl)
|
2003-11-10 |
2007-01-22 |
Microbia, Inc. |
4-Diarylo-1- fenyloazetydyn-2-ony
|
WO2005047253A1
(fr)
|
2003-11-12 |
2005-05-26 |
Lg Life Sciences Ltd. |
Agonistes du récepteur de la mélanocortine
|
JP4795965B2
(ja)
|
2003-11-12 |
2011-10-19 |
エルジー・ライフ・サイエンシーズ・リミテッド |
メラノコルチン受容体のアゴニスト
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
AU2004293012A1
(en)
|
2003-11-19 |
2005-06-09 |
Rustum S. Boyce |
Quinazolinone compounds with reduced bioaccumulation
|
EP1538159A1
(fr)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Dérivés de N-benzyl-lactam comme agonistes du récepteur melanocortine-4
|
WO2005060985A1
(fr)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition volontaire de consommation d'ethanol au moyen d'agonistes du recepteur 4 de la melanocortine
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
ES2282927T3
(es)
|
2003-12-19 |
2007-10-16 |
Bristol-Myers Squibb Company |
Heterociclos azabiciclicos como moduladores de receptores canabinoides.
|
BRPI0417833A
(pt)
|
2003-12-19 |
2007-04-17 |
Biovitrum Ab |
novos derivados de benzofurano, os quais podem ser usados na profilaxia ou tratamento de distúrbios relacionados com o receptor 5-ht6
|
EP1557417B1
(fr)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Dérivés de 8'-pyri(mi)dinyl-dihydrospiro-[cycloaklyamine]-pyrimido[1,2-a]pyrimidin-6-one substitués
|
JP2007514794A
(ja)
|
2003-12-19 |
2007-06-07 |
メルク エンド カムパニー インコーポレーテッド |
環式グアニジン、そのような化合物を含む組成、及び使用方法
|
TW200528455A
(en)
|
2003-12-19 |
2005-09-01 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
EP1699759B1
(fr)
|
2003-12-23 |
2010-10-20 |
AstraZeneca AB |
Derives diphenylazetidinone a activite inhibitrice de l'absorption du cholesterol
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
CN100471835C
(zh)
|
2003-12-23 |
2009-03-25 |
默克公司 |
抗高胆固醇血症化合物
|
CN1898235A
(zh)
|
2003-12-24 |
2007-01-17 |
普罗西迪恩有限公司 |
作为gpcr受体激动剂的杂环衍生物
|
SI1711184T1
(sl)
|
2004-01-06 |
2007-12-31 |
Janssen Pharmaceutica Nv |
(3-okso-3,4-dihidro-kinoksalin-2-il-amino)-benzamidni derivati in sorodne spojine kot inhibitorji glikogen-fosforilaze za zdravljenje diabetesa in debelosti
|
JP2005206492A
(ja)
|
2004-01-21 |
2005-08-04 |
Sankyo Co Ltd |
スルホンアミド化合物
|
DE102004003811A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE602005023124D1
(de)
|
2004-01-28 |
2010-10-07 |
Hoffmann La Roche |
Spirobenzodioxole und deren verwendung als cb1-antagonisten
|
EP1718309A2
(fr)
|
2004-01-30 |
2006-11-08 |
Japan Tobacco, Inc. |
Composes anorexigene
|
JP2007519648A
(ja)
|
2004-01-31 |
2007-07-19 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
7−フェニルアミノ−4−キノロン−3−カルボン酸誘導体、その製造方法及び医薬としての使用
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
BRPI0507801A
(pt)
|
2004-02-17 |
2007-07-10 |
Esteve Labor Dr |
compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
|
US20080312207A1
(en)
|
2004-02-18 |
2008-12-18 |
Craig Johnstone |
Compounds
|
PL1725536T3
(pl)
|
2004-02-19 |
2009-04-30 |
Solvay Pharm Bv |
Pochodne imidazoliny mające czynność CB1-antagonistyczną
|
CA2555331C
(fr)
|
2004-02-20 |
2011-01-04 |
Astrazeneca Ab |
Agents therapeutiques
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
EP1718671A2
(fr)
|
2004-02-23 |
2006-11-08 |
Rheoscience A/S |
Analogues du peptide yy
|
WO2005082893A2
(fr)
|
2004-02-25 |
2005-09-09 |
Eli Lilly And Company |
Antagonistes du recepteur d'histamine h3, leur preparation et leurs utilisations therapeutiques
|
EP1720836B1
(fr)
|
2004-02-25 |
2014-04-16 |
Eli Lilly And Company |
2,3,4,5-tetrahydro-1h-benzo [d]azepines substitues en position 6 en tant qu'agonistes de recepteur 5-ht sb 2c /sb
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
US8058245B2
(en)
|
2004-03-04 |
2011-11-15 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
CA2558272C
(fr)
|
2004-03-05 |
2011-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Derive pyridone
|
PT1751131E
(pt)
|
2004-03-10 |
2009-02-13 |
Janssen Pharmaceutica Nv |
Aril-piperidinas ou aril-piperazinas substituídas com heterociclos de 5 membros inibidoras de mtp
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
GB0406378D0
(en)
|
2004-03-22 |
2004-04-21 |
Karobio Ab |
Novel pharmaceutical compositions
|
AU2005230864A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck Sharp & Dohme Corp. |
Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
EP1586318A1
(fr)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiazolidinones comme inhibiteurs de GSK-3
|
US7608627B2
(en)
|
2004-04-05 |
2009-10-27 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
JPWO2005097738A1
(ja)
|
2004-04-06 |
2008-02-28 |
大日本住友製薬株式会社 |
新規スルホンアミド誘導体
|
EP1734930A2
(fr)
|
2004-04-09 |
2006-12-27 |
Smithkline Beecham Corporation |
Produits pharmaceutiques a faibles doses
|
FR2868780B1
(fr)
|
2004-04-13 |
2008-10-17 |
Sanofi Synthelabo |
Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
|
JPWO2005108370A1
(ja)
|
2004-04-16 |
2008-03-21 |
味の素株式会社 |
ベンゼン化合物
|
AP2006003768A0
(en)
|
2004-05-25 |
2006-10-31 |
Pfizer Prod Inc |
TetraazabenzoÄeÜazulene derivatives and analogs tehereof
|
WO2005118573A1
(fr)
|
2004-05-28 |
2005-12-15 |
Smithkline Beecham Corporation |
Nouveaux composes de diazepine utilises comme ligands des recepteurs 1 et/ou 4 de la melanocortine
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
EA200700119A1
(ru)
|
2004-06-24 |
2007-10-26 |
Эли Лилли Энд Компани |
Соединения и способы лечения дислипидемии
|
CA2569507A1
(fr)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Composes amido et utilisation de ceux-ci comme agents pharmaceutiques
|
MXPA06014415A
(es)
|
2004-06-24 |
2007-02-19 |
Shionogi & Co |
Compuestos de sulfonamida.
|
EP1773780A4
(fr)
|
2004-06-24 |
2008-01-09 |
Incyte Corp |
Composes amido et utilisations de ces derniers en tant que produits pharmaceutiques
|
AU2005260495B2
(en)
|
2004-07-02 |
2009-04-30 |
Sankyo Company, Limited |
Urea derivative
|
WO2006017257A2
(fr)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Derives d'acetidinone
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
GB0416728D0
(en)
|
2004-07-27 |
2004-09-01 |
7Tm Pharma As |
Medicinal use of receptor ligands
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
NZ552398A
(en)
|
2004-07-28 |
2010-08-27 |
Hoffmann La Roche |
Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors for treatment of diabetes
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのスルホニル化合物
|
WO2006018150A1
(fr)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
Cycles a substitution d-xylopyranosyl-phenyle, medicaments contenant ces composes, leur utilisation, et leur procede de production
|
BRPI0514147A
(pt)
|
2004-08-12 |
2008-05-27 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento profilático ou terapêutico de uma condição onde a ativação de gk é desejável, de tratamento profilático ou terapêutico da hiperglicemia ou diabete e de prevenção da diabete em um ser humano que demosntra hiperglicemia pré-diabética ou toleráncia à glicose prejudicada, e, processo para a preparação do composto
|
WO2006019020A1
(fr)
|
2004-08-16 |
2006-02-23 |
Sankyo Company, Limited |
Urées de substitution
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006023515A2
(fr)
|
2004-08-18 |
2006-03-02 |
Metabasis Therapeutics, Inc. |
Nouveaux inhibiteurs thiazole de la fructose 1,6-bisphosphatase
|
CA2576839C
(fr)
|
2004-08-30 |
2013-07-02 |
Janssen Pharmaceutica N.V. |
Derives d'acetamides n-2 adamantanyl-2-phenoxy utilises en tant qu'inhibiteurs de la deshydrogenase 11-beta hydroxysteroide
|
BRPI0515168A
(pt)
|
2004-09-11 |
2008-07-08 |
Sanofi Aventis Deutschland |
7-azaindóis, processos para sua preparação e seu uso como fármacos
|
WO2006035796A1
(fr)
|
2004-09-29 |
2006-04-06 |
Kissei Pharmaceutical Co., Ltd. |
COMPOSÉ HÉTÉROCYCLIQUE AZOTÉ 1-(β-D-GLYCOPYRANOSYL)-3-SUBSTITUÉ, PRÉPARATION THÉRAPEUTIQUE CONTENANT LEDIT COMPOSÉ, ET EMPLOI MÉDICAL DUDIT COMPOSÉ
|
EP1797042B1
(fr)
|
2004-09-29 |
2009-01-07 |
F.Hoffmann-La Roche Ag |
Derives d'indozolone utilises en tant qu'inhibiteurs de la 11b-hsd1
|
CA2582327A1
(fr)
|
2004-10-01 |
2006-04-13 |
Takao Suzuki |
Compose heterocyclique azote substitue en 2 par un groupement arylcarboxamide
|
CN101031300A
(zh)
|
2004-10-01 |
2007-09-05 |
默克公司 |
用于治疗或预防糖尿病的作为二肽基肽酶-ⅳ抑制剂的氨基哌啶化合物
|
EP1799710A2
(fr)
|
2004-10-07 |
2007-06-27 |
Novo Nordisk A/S |
Composes de glp-1 a action prolongee
|
WO2006037811A2
(fr)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Composes d'exendin-4 a action prolongee
|
EP1807409A2
(fr)
|
2004-10-12 |
2007-07-18 |
Pharmacopeia Drug Discovery, Inc. |
Composes bicycliques utilises comme antagonistes du recepteur d'hormone concentrant la melanine selectifs destines au traitement de l'obesite et de troubles associes
|
JP2008515956A
(ja)
|
2004-10-12 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型活性スピロ化合物
|
WO2006044174A2
(fr)
|
2004-10-13 |
2006-04-27 |
Neurogen Corporation |
Composes de 8-azabicyclo[3.2.1]octane a substitution aryle comme ligands du recepteur de l'hormone de concentration de la melanine
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
KR20070070231A
(ko)
|
2004-10-22 |
2007-07-03 |
스미스클라인 비참 코포레이션 |
Hm74a 수용체 활성을 가지는 크산틴 유도체
|
WO2006045564A1
(fr)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Derives de xanthine avec activite du recepteur hm74a
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
PL1807072T3
(pl)
|
2004-10-29 |
2009-06-30 |
Lilly Co Eli |
Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1
|
WO2006048750A2
(fr)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Nouveaux composes d'adamantyl amides substitues ou non
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
EP1666467A1
(fr)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
Inhibiteurs de 11-béta-HSD1
|
EP1659113A1
(fr)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibiteurs de 11 beta hydroxy stéroid dehydrogenase type 1 (11beta-HSD1)
|
WO2006051662A1
(fr)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
Derive de thiazole
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
EP1819674B1
(fr)
|
2004-11-29 |
2011-10-05 |
Merck Sharp & Dohme Corp. |
Aminopiperidines fusionnees utilisees comme inhibiteurs de la dipeptidyle peptidase-iv permettant de traiter ou de prevenir le diabete
|
WO2006059744A1
(fr)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ACTIVANT DE RÉCEPTEUR δ ACTIVÉ PAR UN PROLIFÉRATEUR DE PEROXISOME
|
WO2006058923A1
(fr)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Composés hétéroaromatiques activants de glucokinase
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
CN102633730A
(zh)
|
2004-12-03 |
2012-08-15 |
先灵公司 |
作为cb1拮抗剂的取代哌嗪
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
US7795283B2
(en)
|
2004-12-14 |
2010-09-14 |
Astrazeneca Ab |
Oxadiazole derivative as DGAT inhibitors
|
WO2006065826A2
(fr)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Procede de preparation de derives de beta-aminoacides chiraux par hydrogenation asymetrique
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
JP2008524244A
(ja)
|
2004-12-17 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
水酸化ステロイド脱水素酵素阻害剤
|
US20080194609A1
(en)
|
2004-12-18 |
2008-08-14 |
Bayer Heathcare Ag |
Chemical Compound and Its Use
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
WO2006067443A1
(fr)
|
2004-12-23 |
2006-06-29 |
Astrazeneca Ab |
Agents thérapeutiques
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
WO2006067224A2
(fr)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Nouveaux composes
|
JP2008525401A
(ja)
|
2004-12-23 |
2008-07-17 |
アストラゼネカ アクチボラグ |
治療薬
|
CN101103032B
(zh)
|
2004-12-24 |
2011-05-11 |
大日本住友制药株式会社 |
双环吡咯衍生物
|
JP5065908B2
(ja)
|
2004-12-24 |
2012-11-07 |
プロシディオン・リミテッド |
Gタンパク質結合受容体作動薬
|
BRPI0516407A
(pt)
|
2004-12-24 |
2008-09-02 |
Prosidion Ltd |
agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
|
CA2592514A1
(fr)
|
2004-12-27 |
2006-07-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes mimetiques glucocorticoides, compositions pharmaceutiques les contenant, et methodes de fabrication et d'utilisation de ceux-ci
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
CA2605214C
(fr)
|
2004-12-31 |
2016-07-12 |
Reddy Us Therapeutics, Inc. |
Nouveaux derives de benzylamine en tant qu'inhibiteurs de cetp
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
NZ555966A
(en)
|
2005-01-05 |
2011-03-31 |
Abbott Lab |
Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
WO2006073167A1
(fr)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
Derives de la pyrrolidine
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
CN101107235B
(zh)
|
2005-01-18 |
2011-03-16 |
霍夫曼-拉罗奇有限公司 |
作为5-ht2c激动剂的吗啉类化合物
|
DE602006010320D1
(de)
|
2005-01-19 |
2009-12-24 |
Merck & Co Inc |
Bicyclische pyrimidine als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
JPWO2006082952A1
(ja)
|
2005-02-01 |
2008-06-26 |
武田薬品工業株式会社 |
アミド化合物
|
AU2006210503B2
(en)
|
2005-02-03 |
2009-09-03 |
Irm Llc |
Compounds and compositions as PPAR modulators
|
WO2006086562A2
(fr)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Derives de phenylazetidinone
|
KR20070107000A
(ko)
|
2005-02-15 |
2007-11-06 |
노보 노르디스크 에이/에스 |
3,4-디히드로-1h-이소퀴놀린-2-카르복실산5-아미노피리딘-2-일 에스테르
|
EP1849795B1
(fr)
|
2005-02-15 |
2011-01-26 |
Kissei Pharmaceutical Co., Ltd. |
Compose 1-substitue-7-( -d-glycopyranosyloxy)(aza)indole et produit pharmaceutique contenant celui-ci
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
AR055563A1
(es)
|
2005-02-25 |
2007-08-22 |
Takeda Pharmaceutical |
Compuestos de piridil acido acetico, agente farmaceutico y utilizacion del compuesto para preparar dicho agente
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
US20060229250A1
(en)
|
2005-03-09 |
2006-10-12 |
Jian Zhang |
Ghrelin associated peptide and its uses
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
MX2007012082A
(es)
|
2005-03-31 |
2007-11-20 |
Pfizer Prod Inc |
Derivados de ciclopentapiridina y tetrahidroquinolina.
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
MX2007012110A
(es)
|
2005-04-01 |
2007-11-21 |
Lilly Co Eli |
Agentes del receptor de histamina h3, preparacion y usos terapeuticos.
|
WO2006106054A1
(fr)
|
2005-04-06 |
2006-10-12 |
F. Hoffmann-La Roche Ag |
Derives de pyridine-3-carboxamide utilises comme agonistes inverses des cb1
|
WO2006106423A2
(fr)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Nouveaux composes de derives aminosulfonyles
|
CA2603757A1
(fr)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Agonistes du recepteur de la niacine, compositions les contenant et methodes de traitement
|
DE602006011453D1
(de)
|
2005-04-15 |
2010-02-11 |
Boehringer Ingelheim Pharma |
Glucopyranosyl-substituierte (heteroaryloxy-benzyl)-benzen-derivate als sglt-inhibitoren
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20070078135A1
(en)
|
2005-04-18 |
2007-04-05 |
Neurogen Corporation |
Substituted heteroaryl CB1 antagonists
|
WO2006113919A2
(fr)
|
2005-04-19 |
2006-10-26 |
Bayer Pharmaceuticals Corporation |
Preparation et utilisation de derives de l'acide aryle alkyle dans le traitement de l'obesite
|
EP2308839B1
(fr)
|
2005-04-20 |
2017-03-01 |
Takeda Pharmaceutical Company Limited |
Composés hétérocycliques condensés
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
WO2006111849A1
(fr)
|
2005-04-20 |
2006-10-26 |
Pfizer Products Inc. |
Composes heteromatiques acylaminobicycliques tenant lieu de ligands du recepteur cannabinoide
|
JP2008539255A
(ja)
|
2005-04-26 |
2008-11-13 |
マイクロビア インコーポレーテッド |
高コレステロール血症のための4−ビアリーリル−1−フェニルアゼチジン−2−オングルクロニド誘導体
|
WO2006118320A1
(fr)
|
2005-04-28 |
2006-11-09 |
Takeda Pharmaceutical Company Limited |
Composé de thiénopyrimidone
|
EP1877373A2
(fr)
|
2005-05-05 |
2008-01-16 |
Microbia, Inc. |
Inhibiteurs d'absorption de biphenylazetidinone cholesterol
|
WO2006121860A2
(fr)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Agonistes vis-a-vis du recepteur peptidique de type glucagon 1 (glp-1) et procedes pharmacologiques d'utilisation
|
WO2006120125A1
(fr)
|
2005-05-10 |
2006-11-16 |
F. Hoffmann-La Roche Ag |
Inhibiteurs de diacylglycerol acyltransferase
|
EP1879860A2
(fr)
|
2005-05-10 |
2008-01-23 |
Microbia Inc. |
Derives de 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone utilises dans le traitement de l'hypercholesterolemie
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
BRPI0608970A2
(pt)
|
2005-05-11 |
2010-02-17 |
Microbia Inc |
processos para produção de 4-bifenililazetidin-2-onas fenólicas
|
DE602006017202D1
(de)
|
2005-05-13 |
2010-11-11 |
Lilly Co Eli |
Pegylierte glp-1-verbindungen
|
AU2006247695B2
(en)
|
2005-05-17 |
2012-08-09 |
Merck Sharp & Dohme Corp. |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
WO2007044085A2
(fr)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques
|
WO2007046867A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de piperidine et leurs utilisations comme agents therapeutiques
|
WO2007046868A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de thiazolidine et leurs utilisations en tant qu’agents therapeutiques
|
AU2006251660B2
(en)
|
2005-05-25 |
2011-05-26 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
AU2006249905A1
(en)
|
2005-05-25 |
2006-11-30 |
Microbia, Inc. |
Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
JP2008542365A
(ja)
|
2005-05-31 |
2008-11-27 |
アストラゼネカ・アクチエボラーグ |
新規なmchr1アンタゴニスト並びにmchr1媒介状態及び障害の処置のためのそれらの使用
|
WO2006132436A1
(fr)
|
2005-06-08 |
2006-12-14 |
Japan Tobacco Inc. |
Composé hétérocyclique
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
CN101193869B
(zh)
|
2005-06-10 |
2011-03-02 |
贝林格尔·英格海姆国际有限公司 |
糖皮质激素模拟物、其制备方法、药物组合物及其用途
|
EP1893592A1
(fr)
|
2005-06-11 |
2008-03-05 |
AstraZeneca AB |
Dérivés d oxadiazole en tant qu inhibiteurs de la diacylglycérol acyltransférase (dgat)
|
AU2006259646A1
(en)
|
2005-06-15 |
2006-12-28 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
KR20080016649A
(ko)
|
2005-06-16 |
2008-02-21 |
화이자 인코포레이티드 |
N-(피리딘-2-일)-술폰아미드 유도체
|
WO2006134481A1
(fr)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibiteurs de la 11-beta hydroxysteroide deshydrogenase de type 1
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
EP1928859A1
(fr)
|
2005-06-17 |
2008-06-11 |
Carex SA |
Derives de pyrazole utilises comme modulateurs du recepteur cannabinoide
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
EP1896445B1
(fr)
|
2005-06-22 |
2010-11-10 |
F. Hoffmann-La Roche AG |
( 6-fluorobenzo[1,3] dioxolyl)-morpholin-4-yl-méthanones et leur emploi en tant que ligands de cbi
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057072A1
(es)
|
2005-06-22 |
2007-11-14 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
WO2007001939A1
(fr)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Composes tetrahydro-pyranopyrazole presentant des activites de modulation de cannabinoïde
|
WO2007000445A1
(fr)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Derives de benzyle-benzene a substitution glucopyranosyle, medicaments contenant de tels composes, utilisation et production de ces derniers
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
JP2008545010A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Gタンパク質共役受容体アゴニスト
|
GB0513692D0
(en)
|
2005-07-04 |
2005-08-10 |
Karobio Ab |
Novel pharmaceutical compositions
|
CA2612740C
(fr)
|
2005-07-05 |
2011-07-26 |
F. Hoffmann-La Roche Ag |
Derives de pyridazine
|
JPWO2007007688A1
(ja)
|
2005-07-08 |
2009-01-29 |
持田製薬株式会社 |
3,5−ジアミノ−1,2,4−トリアゾール誘導体
|
JP2009500377A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
ジシクロアルキルウレア型グルコキナーゼ活性化剤
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
AR057661A1
(es)
|
2005-07-11 |
2007-12-12 |
Tanabe Seiyaku Co |
Un derivado de oxima y sus preparaciones
|
WO2007007910A1
(fr)
|
2005-07-13 |
2007-01-18 |
Banyu Pharmaceutical Co., Ltd. |
Dérivé du benzimidazole à substitution par un hétérocycle
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
US7884210B2
(en)
|
2005-07-14 |
2011-02-08 |
Novo Nordisk A/S |
Ureido-thiazole glucokinase activators
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
ES2326952B1
(es)
|
2005-07-15 |
2010-05-28 |
Laboratorios Del Dr. Esteve, S.A. |
Hidratos de (rac) -n-piperidinil-5-(4-clorofenil)-1-(2,4-diclorofenil)4,5-dihidro-1h-pirazol-3-carboxamida.
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
EP1757587A1
(fr)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Composés de pyrazoline substituée, leur préparation et leur usage comme médicaments
|
WO2007009894A2
(fr)
|
2005-07-18 |
2007-01-25 |
Novo Nordisk A/S |
Nouveaux peptides utilises dans le traitement de l'obesite
|
WO2007011811A1
(fr)
|
2005-07-19 |
2007-01-25 |
Merck & Co., Inc. |
Derives de spirochromanone utilises comme inhibiteurs de carboxylase de coenzyme d'acetyle (acc)
|
WO2007009236A1
(fr)
|
2005-07-20 |
2007-01-25 |
Merck Frosst Canada Ltd. |
Composes heteroaromatiques servant d'inhibiteurs d'une coenzyme stearoyle a delta-9 desaturase
|
ATE432259T1
(de)
|
2005-07-20 |
2009-06-15 |
Lilly Co Eli |
Pyridinderivate als dipeptedyl-peptidase-hemmer
|
PT1919878E
(pt)
|
2005-07-21 |
2010-11-02 |
Hoffmann La Roche |
Derivados de piridazinona como agonistas do receptor da hormona da tiróide
|
ATE449097T1
(de)
|
2005-07-21 |
2009-12-15 |
Hoffmann La Roche |
Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
|
WO2007015744A1
(fr)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Composés thiényl bi-substitués et leur utilisation en tant que produits pharmaceutiques
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
WO2007016538A2
(fr)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
|
WO2007017124A1
(fr)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
Phase amorphe d'une pyrazoline substituee, sa preparation et son utilisation comme medicament
|
CA2617042A1
(fr)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Compose spiro-cyclique
|
US7827993B2
(en)
|
2005-07-29 |
2010-11-09 |
Mayo Foundation For Medical Education And Research |
Skin pressure reduction to prevent decubitus ulcers by partial magnetic levitation
|
US8153694B2
(en)
|
2005-07-29 |
2012-04-10 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
WO2007015162A1
(fr)
|
2005-08-04 |
2007-02-08 |
Pfizer Limited |
Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
US20080306087A1
(en)
|
2005-08-08 |
2008-12-11 |
Astrazeneca Ab |
Therapeutic Agents
|
US20100160286A1
(en)
|
2005-08-09 |
2010-06-24 |
Astrazeneca Uk Limited Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
WO2007017261A1
(fr)
|
2005-08-10 |
2007-02-15 |
Smithkline Beecham Corporation |
Dérivés de la xanthine en tant qu’agonistes sélectifs du hm74a
|
WO2007020502A2
(fr)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Ligands des recepteurs de cannabinoide et utilisations de ceux-ci
|
CN101243078A
(zh)
|
2005-08-18 |
2008-08-13 |
霍夫曼-拉罗奇有限公司 |
噻唑基哌啶衍生物
|
CA2619770A1
(fr)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
Derive phenylpyridone
|
EP1921917B1
(fr)
|
2005-08-26 |
2012-03-21 |
Merck Sharp & Dohme Corp. |
Aminopiperidines fusionnees utilisees comme inhibiteurs de dipeptidyl-peptidase-iv pour le traitement ou la prevention du diabete
|
WO2007026215A1
(fr)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Dérivés de pyrazole tels que les ligands du récepteur de cannabinoïde, compositions pharmaceutiques les contenant et procédés pour leur préparation
|
CA2620570A1
(fr)
|
2005-08-29 |
2007-03-08 |
Merck & Co., Inc. |
Agonistes des recepteurs de l'acide nicotinique, compositions contenant ces composes et methodes de traitement
|
EP1921074A1
(fr)
|
2005-08-31 |
2008-05-14 |
Astellas Pharma Inc. |
Dérivé de thiazole
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(fr)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents et procede permettant de reduire l'activite de la proteine tyrosine phosphatase 1b dans le systeme nerveux central
|
WO2007029086A2
(fr)
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Derives de 3-azabicyclo[3.1.0]hexane en tant qu'inhibiteurs de la dipeptidyl peptidase-iv
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
EP1924546A1
(fr)
|
2005-09-14 |
2008-05-28 |
Amgen, Inc |
Acides propanoïques 3-substitués par un groupement 4-hydroxyphényle à conformation contrainte pouvant être employés dans le traitement de troubles métaboliques
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
NZ565898A
(en)
|
2005-09-16 |
2010-07-30 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
CN101263140A
(zh)
|
2005-09-16 |
2008-09-10 |
阿斯利康(瑞典)有限公司 |
作为葡萄糖激酶活化剂的杂双环化合物
|
GB0519294D0
(en)
|
2005-09-21 |
2005-11-02 |
Karobio Ab |
Compounds
|
ATE516301T1
(de)
|
2005-09-21 |
2011-07-15 |
7Tm Pharma As |
Y2-selektive rezeptoragonisten für therapeutische eingriffe
|
EP1931652A2
(fr)
|
2005-09-21 |
2008-06-18 |
Incyte Corporation |
Utilisation pharmaceutique de composes amido
|
CN101268099A
(zh)
|
2005-09-21 |
2008-09-17 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y4选择性受体激动剂
|
CA2623525A1
(fr)
|
2005-09-23 |
2007-04-05 |
Janssen Pharmaceutica N.V. |
Modulateurs cannabinoides tetrahydro-indazolyle
|
EA200800889A1
(ru)
|
2005-09-23 |
2008-12-30 |
Янссен Фармацевтика, Н. В. |
Гексагидроциклооктилпиразольные каннабиноидные модуляторы
|
EP1940842B1
(fr)
|
2005-09-29 |
2012-05-30 |
Merck Sharp & Dohme Corp. |
Dérivés acylés de spiropipéridine en tant que modulateurs du récepteur de la mélanocortine-4
|
RU2008112201A
(ru)
|
2005-09-29 |
2009-10-10 |
Санофи-Авентис (Fr) |
Производные фенил- и пиридил-1, 2, 4-оксадиазолона с фенильной группой, способы их получения и их применение в качестве фармацевтических средств
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
WO2007037534A1
(fr)
|
2005-09-30 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
Derive indole substitue en position 2 par un groupe heteroaryle
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
JP2009513573A
(ja)
|
2005-09-30 |
2009-04-02 |
メルク エンド カムパニー インコーポレーテッド |
コレステリルエステル転送蛋白阻害剤
|
AU2006296171A1
(en)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
US20100160306A1
(en)
|
2005-09-30 |
2010-06-24 |
Bakshi Raman K |
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
AU2006298852A1
(en)
|
2005-09-30 |
2007-04-12 |
F. Hoffmann-La Roche Ag |
Indane derivatives as MCH receptor antagonists
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
FR2891825B1
(fr)
|
2005-10-12 |
2007-12-14 |
Sanofi Aventis Sa |
Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
WO2007047737A1
(fr)
|
2005-10-17 |
2007-04-26 |
Acadia Pharmaceuticals Inc. |
Composes modulateurs de cb-1 et leur utilisation
|
US7981910B2
(en)
|
2005-10-20 |
2011-07-19 |
Merck Sharp & Dohme Corp. |
Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
|
CA2623982C
(fr)
|
2005-10-21 |
2012-01-10 |
Mitsubishi Tanabe Pharma Corporation |
Composes pyrazolo[1,5-a]pyrimidine utilises en tant qu'antagonistes du recepteur cannabinoide
|
AR056155A1
(es)
|
2005-10-26 |
2007-09-19 |
Bristol Myers Squibb Co |
Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
CN101296906A
(zh)
|
2005-10-26 |
2008-10-29 |
贝林格尔·英格海姆国际有限公司 |
具有mch拮抗活性的(杂)芳基化合物及包含这些化合物的药物
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
WO2007053765A2
(fr)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Cycloalkylpyrrolones substitues utilises en tant que modulateurs allosteriques de glucokinase
|
WO2007051811A2
(fr)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma |
Utilisation pharmaceutique d'amides substitues
|
US8933077B2
(en)
|
2005-11-01 |
2015-01-13 |
Array Biopharma Inc. |
Glucokinase activators
|
EA200801243A1
(ru)
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
JP2009514835A
(ja)
|
2005-11-03 |
2009-04-09 |
プロシディオン・リミテッド |
トリシクロ置換型アミド
|
AU2006310475A1
(en)
|
2005-11-03 |
2007-05-10 |
Prosidion Ltd |
Tricyclo substituted amides
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
WO2007054257A2
(fr)
|
2005-11-08 |
2007-05-18 |
Laboratorios Del Dr. Esteve, S.A. |
Derives d'indene, leur preparation et leur utilisation en tant que medicaments
|
US20070114078A1
(en)
|
2005-11-09 |
2007-05-24 |
Ososanya Esther T |
Super hybrid and enhanced electric cars
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|